Skip to main content
. Author manuscript; available in PMC: 2019 Apr 24.
Published in final edited form as: Int J Infect Dis. 2019 Feb 14;81:149–155. doi: 10.1016/j.ijid.2019.02.004

Figure 2.

Figure 2.

Evolution of MDR-TB diagnosis over time among suspected.Despite that the number of suspected patients referred did not vary significantly in the first seven years, the number of MDR-TB remained on treatment has increased over time. During the last 3 years, more than 90% of referred patients have been diagnosed as MDR-TB cases. The use of GeneXpert MTB/RIF® in routine care starting in 2014 has positively impacted health professionals’ decision in the management of drug-resistant tuberculosis in Mali.